Thijs van Schaik

MedicineImmunology and MicrobiologyChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?”.

Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?

Frontiers in Oncology(2021)10.3389/fonc.2021.678562

N/A

0DataRank · unranked

30 citations

Kok‐Siong Chen, Khalid Shah, Thijs van Schaik

Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity

Science Translational Medicine(2023)10.1126/scitranslmed.abo4778

N/A

0DataRank · unranked

74 citations

Clemens Reinshagen, Thijs van Schaik, Filippo Rossignoli, Paulo Borges, Natalia Claire Mendonca +6 more

Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas

Science Translational Medicine(2023)10.1126/scitranslmed.ade8732

N/A

0DataRank · unranked

26 citations

Yohei Kitamura, María López Vázquez, Arnaldo Franco, Kok‐Siong Chen, Thijs van Schaik +11 more

Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors

Biomedicine & Pharmacotherapy(2023)10.1016/j.biopha.2023.114665

N/A

0DataRank · unranked

16 citations

Lucia Moreno-Lama, Touraj Aligholipour Farzani, Mian Wang, Kok‐Siong Chen, Wanlu Li +4 more

Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Frontiers in Immunology(2024)10.3389/fimmu.2023.1324618

N/A

0DataRank · unranked

13 citations

Thijs van Schaik, Kok‐Siong Chen, Filippo Rossignoli, Paulo Borges, Vladimir Vrbanac +3 more